Corneal Biomechanical Properties in Childhood Obesity

医学 Scheimpflug原理 眼科 眼压 角膜 肥胖 角膜测厚术 前房角 角膜地形图 内科学
作者
Mehmet Mustafa Can,Hasan Kiziltoprak,Ayşe Derya Buluş,Dilara Özkoyuncu,Mustafa Koc,Zeki Yildiz
出处
期刊:Journal of Pediatric Ophthalmology & Strabismus [Slack Incorporated (United States)]
卷期号:57 (2): 103-107 被引量:1
标识
DOI:10.3928/01913913-20200131-02
摘要

Purpose: To investigate corneal biomechanical properties in patients with childhood obesity. Methods: The study included 47 patients with childhood obesity (study group) and 39 healthy patients (control group). Corneal hysteresis, corneal resistance factor, corneal compensated intraocular pressure (IOPcc), and Goldmann-correlated IOP (IOPg) were measured with the Ocular Response Analyzer (Reichert, Ophthalmic Instruments, Buffalo, NY) in each eye. Central corneal thickness (CCT), anterior chamber angle (ACA), anterior chamber volume (ACV), and anterior chamber depth (ACD) measurements were obtained by the Pentacam rotating Scheimpflug camera (Oculus Optikgeräte GmBh, Wetzlar, Germany). Results: The mean corneal hysteresis was 10.56 ± 1.52 mm Hg in the study group and 11.16 ± 1.92 mm Hg in the control group ( P = .022). The mean IOP was 14.9 ± 2.0 mm Hg in the study group and 14.1 ± 1.3 mm Hg in the control group ( P = .003). Corneal hysteresis showed a significant, positive correlation with corneal resistance factor ( P < .001, r = 0.851), IOPg ( P = .044, r = 0.213), CCT ( P < .001, r = 0.477), and IOP ( P = .005, r = 0.295). Corneal hysteresis showed a significant, negative correlation with IOPcc ( P = .001, r = −0.355), ACA ( P = .005, r = −0.294), ACV ( P = .019, r = −0.246), and ACD ( P = .046, r = −0.211). Conclusions: Patients with childhood obesity have lower corneal hysteresis and higher IOPcc measurements when compared with healthy patients. Corneal tissue changes may occur in early life in childhood obesity, which could lead to ocular disease in the future. [ J Pediatr Ophthalmol Strabismus . 2020;57(2):103–107.]

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Jonathan完成签到,获得积分10
刚刚
刚刚
饼应dundun完成签到,获得积分20
1秒前
mirror应助金金采纳,获得10
3秒前
兵王应助金金采纳,获得10
3秒前
Ava应助CanadaPaoKing采纳,获得10
3秒前
4秒前
杨123完成签到,获得积分10
4秒前
7秒前
文章快快来完成签到,获得积分10
7秒前
领导范儿应助无语的灵凡采纳,获得10
8秒前
小巧的昊强完成签到,获得积分10
10秒前
11秒前
霓霓发布了新的文献求助10
11秒前
12秒前
LY完成签到,获得积分10
15秒前
16秒前
16秒前
NexusExplorer应助你求我一下采纳,获得10
17秒前
18秒前
霓霓完成签到,获得积分10
19秒前
21秒前
Akim应助科研狗采纳,获得10
22秒前
无极微光应助xicifish采纳,获得20
23秒前
慈祥的不愁完成签到,获得积分10
25秒前
25秒前
26秒前
27秒前
27秒前
27秒前
苦哈哈发布了新的文献求助10
30秒前
桐桐应助Moto_Fang采纳,获得10
30秒前
爆米花应助薄薄的厚片采纳,获得10
30秒前
春风十里发布了新的文献求助10
31秒前
Sojourner完成签到,获得积分10
32秒前
lizishu应助Andyvictory采纳,获得10
32秒前
啵啵发布了新的文献求助10
33秒前
wennnnn发布了新的文献求助10
33秒前
酷波er应助科研通管家采纳,获得10
34秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
Elgar Concise Encyclopedia of Space Law 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6943815
求助须知:如何正确求助?哪些是违规求助? 8629338
关于积分的说明 18304845
捐赠科研通 6378618
什么是DOI,文献DOI怎么找? 3079068
关于科研通互助平台的介绍 2119722
邀请新用户注册赠送积分活动 2056006